E-Based Technology to Provide Decision Aid on Breast Reconstruction for Women With Breast Cance

Sponsor
National Cheng-Kung University Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04190992
Collaborator
National Cheng Kung University (Other)
176
1
2
43.9
4

Study Details

Study Description

Brief Summary

Using decision aids has been demonstrated to support women to make treatment decision effectively. However, these studies focused on the decision of receiving breast conservative surgery or mastectomy, had short term follow-ups on decision satisfaction.The aims of this study were: Evaluate the effect of E-based & personalized breast reconstruction surgery decision aid on women's decision satisfaction and mental health.

Condition or Disease Intervention/Treatment Phase
  • Other: E-based & personalized breast reconstruction surgery decision aid
  • Other: Usual care
N/A

Detailed Description

Randomized controlled trial will be used to examine the effect of E-based & personalized breast reconstruction surgery decision aid on decision satisfaction, body image, anxiety and depression. Participants will be randomly assigned into either experimental or control groups with 88 women in each group. After completing the questionnaires at baseline, participants in the experimental group will be asked to receive a E-based & personalized breast reconstruction surgery decision aid at clinic. Control group will only receive pamphlet and usual care. All participants will be followed up 1 week after consultation, and 1 month, 8 month and 12 month after surgery.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
176 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
The Effect of E-Based Technology to Provide Personalized Decision Aid on Breast Reconstruction for Women With Breast Cancer
Actual Study Start Date :
May 5, 2017
Actual Primary Completion Date :
Jul 25, 2019
Anticipated Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Application (APP) group

After completing the questionnaires at baseline, participants in the experimental group will be asked to receive a pamphlet and an E-based & personalized breast reconstruction surgery decision aid at clinic.

Other: E-based & personalized breast reconstruction surgery decision aid
This decision aid contains information regarding surgical options, including breast reconstruction and mastectomy, such as the advantages and disadvantages, the complication probabilities of each option, a value clarification exercise for the patient's self-evaluation, and a summary of the participant's decision-making process.
Other Names:
  • APP decision aid
  • Other: Usual care
    A pamphlet introduce the introduction of types of surgery

    Other: Usual care group

    After completing the questionnaires at baseline, participants in the control group will only receive a pamphlet as usual care

    Other: Usual care
    A pamphlet introduce the introduction of types of surgery

    Outcome Measures

    Primary Outcome Measures

    1. Body image [Pre-surgery, 1 month, 8 month, 12 month post surgery]

      The Body Image Scale (BIS) has ten items rated on a four-point Likert scale (0 [not at all] to 3 [very much]), with total scores ranging from 0 to 30. Higher scores indicate greater BI distress.

    2. Decision Regret [1 month, 8 month, 12 month post surgery]

      Decision Regret Scale (DRS) accesses "distress or remorse after a surgery decision". This instrument contains 5 items. The items were summed, divided by 5, and multiplied by 25. Higher scores indicate greater decision regret.

    3. Decision conflict [Pre-surgery, 1 week after intervention]

      Decision Conflict Scale (DCS) accesses the perception of uncertainty in information, values or support for surgery options. This instrument contains 16 items and was developed by O'Connor. The items were summed, divided by 16, and multiplied by 25. Higher scores indicate greater decision conflict.

    Secondary Outcome Measures

    1. Anxiety [Pre-surgery, 1 month, 8 month, 12 month post surgery]

      The Hospital Anxiety and Depression Scale (HADS) assesses symptoms of anxiety and depression. The HADS includes 14 items, of which 7 measure anxiety, and 7 measure depression. All items are scored using a 0-3 point scale, with higher scores indicating more depressive symptoms. Cut-off scores are used to categorize anxiety and depressive symptoms, with values of over 8 indicating possible anxiety and depression, and 11 or above indicating probable anxiety.

    2. Depression [Pre-surgery, 1 month, 8 month, 12 month post surgery]

      The Hospital Anxiety and Depression Scale (HADS) assesses symptoms of anxiety and depression. The HADS includes 14 items, of which 7 measure anxiety, and 7 measure depression. All items are scored using a 0-3 point scale, with higher scores indicating more depressive symptoms. Cut-off scores are used to categorize anxiety and depressive symptoms, with values of over 8 indicating possible anxiety and depression, and 11 or above indicating probable depression.

    3. Involvement in the Breast Reconstruction (BR) decision-making process scale [1 week after intervention]

      Involvement in the BR decision-making process was divided into two subscales, one accesses the perception of medical information about surgery obtained with 6 items and the other assesses the perception of partners' involvement in the BR decision-making process with 7 items. The scale used a five-point Likert scale (1 [strongly disagree] to 5 [strongly agree]); the higher the score, the greater the amount of information the participants believed they had obtained and the greater the participants perceived their partner's involvement in the BR decision-making process.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • age of at least 20 years or under 20 years but married

    • females newly diagnosed with breast cancer who are candidates for mastectomy

    • ability to read and speak Taiwanese or Mandarin

    Exclusion Criteria:
    • Women with cancer recurrence

    • poor cognitive function

    • diagnosed with psychiatric disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National Cheng Kung University Hospital Tainan Taiwan

    Sponsors and Collaborators

    • National Cheng-Kung University Hospital
    • National Cheng Kung University

    Investigators

    • Principal Investigator: Su-Ying Fang, PhD, National Cheng Kung University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Su-Ying Fang, Associate Professor, National Cheng Kung University
    ClinicalTrials.gov Identifier:
    NCT04190992
    Other Study ID Numbers:
    • B-ER-106-072
    First Posted:
    Dec 9, 2019
    Last Update Posted:
    Dec 9, 2019
    Last Verified:
    Dec 1, 2019
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Su-Ying Fang, Associate Professor, National Cheng Kung University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 9, 2019